CA
NZ
UK
AU
IND
US
Skyworks Solutions, Inc. filed a Form 8-K under Rule 425 on August 3, 2026, disclosing the current regulatory status of its previously announced merger with Qorvo, Inc., including the expiration of the FTC timing agreement and the remaining open jurisdictions in China and South …
Bit Digital, Inc. (NASDAQ: BTBT) filed a Form 8-K on August 3, 2026, disclosing that Justin Zhu notified the Board of Directors on July 30, 2026 of his resignation as Senior Vice President of Finance and Chief Accounting Officer, effective August 1, 2026.
CNH Industrial N.V. filed a current report on Form 8-K with the SEC on August 3, 2026, announcing the availability of its second quarter 2026 results of operations via a press release and an investor presentation.
Brookfield Asset Management Ltd. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 3, 2026, reporting the completion of its previously announced acquisition of the remaining 26% interest in Oaktree Capital Group, bringing Brookfield's ownership to 100%.
Strive, Inc. filed a Form 8-K with the SEC on August 3, 2026, disclosing a bitcoin purchase made during the period July 27 through July 31, 2026, and providing updated balance data for cash, bitcoin, preferred stock holdings, and share counts as of July …
W.W. Grainger, Inc. filed a current report with the SEC on August 3, 2026, disclosing the resignation of Chief Financial Officer Deidra C. Merriwether and the appointment of Laurie R. Thomson as interim CFO, both effective in early September 2026.
Strategy Inc (NASDAQ: MSTR) filed a current report on Form 8-K on August 3, 2026, disclosing at-the-market equity sales, bitcoin transactions, share repurchases, and dividend declarations for the period ending August 2, 2026.
AGCO Corporation (NYSE: AGCO) filed a Form 8-K on August 3, 2026, disclosing executive leadership changes effective August 1, 2026, including the appointment of Indira Agarwal as Senior Vice President and Chief Financial Officer.
Autolus Therapeutics plc filed a Form 8-K on July 30, 2026, disclosing that it entered into a senior secured notes facility of up to $250.0 million with Perceptive Credit Holdings V, LP as administrative agent, and simultaneously issued warrants to purchase up to 3,500,000 …
Autolus Therapeutics plc filed a Form 8-K on August 3, 2026, announcing an increase to its full-year 2026 net product revenue guidance for AUCATZYL, anticipated Q2 2026 revenue figures, gross margin expectations, a new credit facility, and an updated cash runway outlook.
Please wait processing your request...